Keros Therapeutics (KROS) Stock Chart & Stock Price History $14.16 +0.12 (+0.85%) Closing price 04:00 PM EasternExtended Trading$14.17 +0.01 (+0.07%) As of 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Keros Therapeutics Stock Price Performance The Keros Therapeutics (KROS) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 72.30%, with a year-to-date return of -10.55%. In the past month, the stock has increased 1.94%, reflecting recent market activity. As of the latest close, Keros Therapeutics traded at $14.04 with a market cap of $570.24 million and volume of 625,350 shares. Five years ago, the stock traded at $27.31, representing a 48.15% decrease over that period. At the time, it had a market cap of $515.35 million and a volume of 29,480 shares. Receive KROS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Keros Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+0.64%1 Month Performance+1.94%3 Month Performance+28.67%Year-To-Date Performance-10.55%1 Year Performance-72.30%5 Year Performance-48.15% KROS Stock Chart for Thursday, May, 22, 2025 KROS Chart by TradingView Keros Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/21/2025$14.14$14.04-0.71%$14.28$13.72625,350 shs$570.24 million05/20/2025$14.10$14.14+0.28%$14.25$13.91721,794 shs$574.30 million05/19/2025$14.07$14.10+0.21%$14.44$13.95579,029 shs$572.67 million05/16/2025$14.03$14.07+0.29%$14.22$13.76633,971 shs$571.45 million05/15/2025$13.59$14.03+3.24%$14.04$13.391.26 million shs$569.83 million05/14/2025$13.47$13.59+0.89%$13.75$13.14624,935 shs$551.96 million05/13/2025$13.74$13.47-1.97%$13.71$13.21537,980 shs$547.08 million05/12/2025$13.65$13.74+0.66%$14.24$13.441.22 million shs$558.05 million05/09/2025$14.02$13.65-2.64%$14.22$13.57546,340 shs$554.40 million05/08/2025$13.68$14.02+2.47%$14.39$13.54953,638 shs$569.37 million Get the Latest News and Ratings for KROS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Keros Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/07/2025$13.76$13.68-0.57%$14.30$13.431.00 million shs$555.64 million05/06/2025$14.56$13.76-5.49%$14.50$13.501.04 million shs$558.81 million05/05/2025$14.65$14.56-0.61%$14.80$14.16584,379 shs$591.30 million05/02/2025$14.57$14.65+0.55%$14.82$14.51651,753 shs$594.95 million05/01/2025$14.44$14.57+0.90%$14.65$14.18689,118 shs$591.70 million04/30/2025$14.45$14.44-0.07%$14.60$14.27746,575 shs$586.42 million04/29/2025$14.26$14.45+1.33%$14.56$14.011.08 million shs$586.83 million04/28/2025$14.21$14.26+0.35%$14.46$14.09840,384 shs$578.41 million04/25/2025$14.42$14.21-1.46%$14.45$14.141.00 million shs$576.39 million04/24/2025$14.30$14.42+0.84%$14.52$14.041.16 million shs$584.90 million04/23/2025$13.89$14.30+2.95%$14.61$14.061.22 million shs$580.04 million04/22/2025$14.30$13.89-2.87%$14.40$13.85870,382 shs$563.41 million04/21/2025$14.07$14.30+1.63%$14.67$13.831.25 million shs$580.04 million Related Companies Vericel Stock Price Chart Arrowhead Pharmaceuticals Stock Price Chart Belite Bio Stock Price Chart Apellis Pharmaceuticals Stock Price Chart NewAmsterdam Pharma Stock Price Chart Denali Therapeutics Stock Price Chart Gemini Therapeutics Stock Price Chart Ascentage Pharma Group International Stock Price Chart Harmony Biosciences Stock Price Chart Kymera Therapeutics Stock Price Chart Receive KROS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Keros Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:KROS) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredThe Collapse Has Already Started — Your 401(k) Is NextThere's a major heist happening on American wealth in real time. Except this one doesn't involve masks or v...American Hartford Gold | SponsoredElon’s 2025 Silver Crisis (What It Means for You)Elon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless p...GoldenCrest Metals | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredThe DOJ Just Said Your Money Isn’t YoursWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Keros Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Keros Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy KROS Stock Free KROS Stock Alerts